Table 2.
Patient-reported measures, current medication use, and ultrasound examination in patients with childhood-onset systemic lupus erythematosus
| N = 31 (%)a | |
|---|---|
| Patient-reported measures | |
| Dryness Scoreb, Median (IQR) | 2.0 (0.0–4.0) |
| Fatigue Scoreb, Median (IQR) | 2.0 (1.0–5.0) |
| Pain Scoreb, Median (IQR) | 1.0 (0.0–3.0) |
| Needs water to swallow | 7 (23) |
| Episodic cheek swelling | 4 (13) |
| Medications | |
| Hydroxychloroquinec | 30 (97) |
| Mycophenolatec | 22 (71) |
| Azathioprinec | 1 (3) |
| Cyclophosphamidec | 1 (3) |
| Rituximabc | 0 (0) |
| Prednisonec | 13 (42) |
| Prednisone, mg, Mean dose | 13.8 |
| Ultrasound examination | |
| US examination time, minutes, Mean | 5.0 |
| US scoring time, minutes, Mean | 2.0 |
| Abnormal SGUS scored | 11 (35) |
a Number of patients with percentage unless noted; bDryness, Fatigue, and Pain scores on a scale of 0–10 with 10 being the worst score; cMedication use within the last month; dAbnormal SGUS score is a score of 2 or 3 as defined by Theander & Mandl [12]